h breakthrough soft tissue fixation technology. Coapt's
revolutionary platform technology for soft tissue fixation enables surgeons
to reduce operating time, facilitate minimally invasive procedures,
minimize procedural complexity, and achieve improved surgical outcomes.
Coapt's patented ENDOTINE family of products are used for plastic surgery
procedures that require accurate soft tissue fixation either to opposing
soft tissue or to bone. The ENDOTINE product line is becoming the standard
of care in aesthetic facial procedures.
"Coapt Systems has all the necessary elements, including strong
management and an innovative product line, to continue its strong pace of
growth and expansion," said Brent Ahrens, general partner at Canaan
Partners. "Coapt is a great example of the type of innovative, high-growth
company meeting unmet medical needs we invest in at Canaan. Laureen is a
great addition to the team with her extensive management experience and
recent success in the growing field of non-invasive aesthetics. Under her
leadership, Coapt is poised to achieve even greater success moving
forward."
Prior to joining Thermage in 2003, DeBuono was a consulting EVP and CFO
to several public and private technology and medical device companies.
DeBuono was also EVP, COO and CFO of More.com, an Internet health products
commerce company, and she was EVP, COO and CFO of Resound Corporation, a
public, hearing products and communications company that was acquired by GN
Great Nordic in 1999. She also served as EVP, General Counsel to Nellcor
Puritan Bennett Inc., a $900M public respiratory products company, from
1992-1998, and negotiated the sale of the company to Mallinkcrodt, Inc. in
1998. She was a member of the Board of Directors of Invivo, Inc., a public
patient safety monitoring company, from 1998-2004, and of VISX, Inc., a
public vision correction company, from 2003-2005, both of which were
acquired. DeBuono received her J.D. from New York University Law School,
'/>"/>
SOURCE Coapt Systems Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market2.
Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems3.
BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery4.
Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway5.
NxStage Medical Provides Update on Medisystems Acquisition6.
ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems7.
Imaging Diagnostic Systems New Laser Breast Imaging Scanner Introduced in Malaysia8.
Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 20079.
Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments10.
Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge11.
Ingenuity Systems Joins Biomarkers Consortium